Odyssey Therapeutics ODTX Income Statement (2023-2026)

NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST
Reported Financials

Odyssey Therapeutics Quarterly Income Statement

Periods 9 quarters
Latest Sep 2026

Odyssey Therapeutics reported net income of -$53.54M for the quarter ended Sep 2026. This income statement covers 9 quarters of results from Dec 2023 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2023 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue 0.29M1.76M1.92M0.96M0.10M
Operating items
Research & DevelopmentR&D 25.80M31.48M38.77M30.23M26.33M31.29M32.32M36.23M42.12M
Selling, General & AdministrativeSG&A 5.31M7.40M7.95M13.22M10.16M6.19M7.35M10.51M11.24M
Other Operating ExpensesOther Opex 0.37M0.38M-5.65M-0.57M1.87M0.30M0.11M8.73M3.31M
Operating ExpensesOpex 31.48M39.26M41.08M42.88M38.35M37.77M39.78M55.47M56.67M
Operating IncomeOp. Inc -31.19M-37.50M-39.16M-41.92M-38.25M-37.77M-39.78M-55.47M-56.67M
Non-operating items
Non Operating Interest Expenses -0.01M0.00M0.00M0.00M0.00M-0.02M0.01M0.02M0.01M
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales 0.36M-0.13M-0.01M0.01M-0.12M0.22M-0.09M-0.47M-0.66M
Interest & Investment IncomeInt & Inv Inc 2.52M1.77M1.16M0.87M2.20M2.12M1.71M2.83M3.86M
Other Non Operating IncomeOther Non Op Inc. -0.09M-0.15M-0.29M-0.15M0.54M1.11M-0.12M-0.14M-0.19M
Non Operating IncomeNon Op. Inc. 2.43M1.62M0.87M0.72M2.74M3.22M1.58M2.67M3.66M
Net income details
EBIT -31.19M-37.50M-39.16M-41.92M-38.25M-37.77M-39.78M-55.47M-56.67M
EBT -28.76M-35.89M-38.30M-41.21M-35.52M-34.56M-38.20M-52.80M-53.01M
Tax ProvisionsTaxes 0.10M0.05M0.14M0.03M-0.06M-1.04M0.06M-0.01M0.05M
Income After Tax -28.86M-35.93M-38.44M-41.24M-35.46M-33.52M-38.26M-52.79M-53.06M
Income from Continuing OperationsIncome (Continuing) -28.86M-35.93M-38.44M-41.24M-35.46M-33.52M-38.26M-52.79M-53.06M
Consolidated Net IncomeConsol Net Inc. -27.38M-35.76M-37.87M-39.92M-35.99M-33.29M-38.65M-53.15M-53.54M
Income towards Parent CompanyParent Net Inc -28.86M-35.93M-38.44M-41.24M-35.46M-33.52M-38.26M-52.79M-53.06M
Net Income towards Common StockholdersNet Income -33.84M-36.84M-38.44M-41.24M-35.46M-33.52M-38.26M-52.79M-53.06M
Additional items
EPS (Basic) -39.37-29.54-7.78-7.35-6.77-1.74-1.10
EPS (Diluted) -39.37-29.54-7.78-7.35-6.77-1.74-1.10
Shares Outstanding 0.98M1.40M4.56M4.56M5.66M30.28M48.02M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 0.98M1.40M4.56M4.56M5.66M30.28M48.02M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 0.99M1.40M4.56M5.66M30.28M47.94M
EBITDA -29.96M-36.21M-32.42M-40.65M-37.07M-36.62M-38.61M-54.43M-55.66M
Interest ExpensesInt Expense -0.01M0.00M0.00M0.00M0.00M-0.02M0.01M0.02M0.01M

Odyssey Therapeutics Income Statement API

Pull Odyssey Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ODTX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY